TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/25 19:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | 4 | 9 | P.dm | 13,307 | 2.05 | 0 | 6,485 | 33 | 26,327 | D | ||||||||||||||
1/16/25 15:28 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 2 | P | 419 | 11.06 | 0 | 38 | 13 | 331 | D | ||||||||||||||
12/13/24 16:12 | 12/11/24 | QDEL | Quidelortho Corp | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 250 | 41.42 | 0 | 6 | 6 | I | ||||||||||||||||
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 4 | 4 | P | 255 | 0.5722 | 0 | 446 | 6 | 8,125 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |